Notably, we showed a posttranscriptional mechanism by which JQ1 and ARV-825-mediated inhibition or degradation of BRD4 increases Aβ levels through regulating BACE1 and APP processing in AD cell models. Here, BRD4 is linked to Alzheimer disease.